APA (7th ed.) Citation

Liang, T., Liu, S., Dang, B., Luan, X., Guo, Y., Steimbach, R. R., . . . Chen, X. (2026). Corrigendum to ‘Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease’ [Eur. J. Med. Chem. 275 (2024) 116624]. European journal of medicinal chemistry, 301, . https://doi.org/10.1016/j.ejmech.2025.118254

Chicago Style (17th ed.) Citation

Liang, Ting, et al. "Corrigendum to ‘Multimechanism Biological Profiling of Tetrahydro-β-carboline Analogues as Selective HDAC6 Inhibitors for the Treatment of Alzheimer's Disease’ [Eur. J. Med. Chem. 275 (2024) 116624]." European Journal of Medicinal Chemistry 301 (2026). https://doi.org/10.1016/j.ejmech.2025.118254.

MLA (9th ed.) Citation

Liang, Ting, et al. "Corrigendum to ‘Multimechanism Biological Profiling of Tetrahydro-β-carboline Analogues as Selective HDAC6 Inhibitors for the Treatment of Alzheimer's Disease’ [Eur. J. Med. Chem. 275 (2024) 116624]." European Journal of Medicinal Chemistry, vol. 301, 2026, https://doi.org/10.1016/j.ejmech.2025.118254.